CRISPR Therapeutics AG (CRSP)

Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell

$50.80

Buy

$51.18

arrow-up$0.33 (+0.65%)

Prices updated at 29 Nov 2024, 21:58 EST
| Prices minimum 15 mins delay
|
Prices in USD
CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics.
NASDAQ
arrow-up0.83%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
$51.67 - $50.25
$91.10 - $43.42
-
4,367.54m
-
-
757,701
2.25
1,751,130.81
1.74
80.21m
CH0334081137
-2.79
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2024 Morningstar. All rights reserved.